Pure Global
NCT06380010

Mediterranean Diet Intervention in Adolescents With Polycystic Ovary Syndrome

Optimizing Dietary Habits in Adolescents With Polycystic Ovary Syndrome: Personalized Mediterranean Diet Intervention Via Clinical Decision Support System. A Randomized Controlled Trial
Iaso Maternity Hospital, Athens, Greece·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Polycystic Ovary Syndrome
Drug/Device/Intervention
Mediterranean diet group
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Iaso Maternity Hospital, Athens, Greece
Location
Athens, Greece
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2019
End date
Jun 30, 2020
Enrollment
40 participants
Primary outcome

Adherance to the Mediterranean diet

Summary

The aim of the present randomized controlled study was to examine wether a clinical decision
 support stystem would increase the adherence to the Mediterranean diet (MD) of adolescent
 girls, aged 15-17 years, diagnosed with polycystic ovary syndrome. The intervention lasted
 for 3 months and in total, 40 girls were randomly assigned to either the MD group (n=20) or a
 Control group receiving general nutritional advice (n=20). Anthropometry, nutritional intake,
 psychological well-being, and blood markers were analyzed at the begninning and the end of
 the trial.

ICD-10 classifications
Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionNeoplasm of uncertain or unknown behaviour: Ovary
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06380010
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06380010 through Pure Global AI's free database. This phase not specified trial is sponsored by Iaso Maternity Hospital, Athens, Greece and is currently Completed. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.